Bio-Imaging Technologies to sell CapMed Division to Metavante - The Business Journal of Milwaukee:

batyushkinuxit.blogspot.com
The details of the future earn-out paymente from Metavante (NYSE:MV) of Milwaukee were not immediately available. The CapMed division, which the Newtown, Pa., clinicalp research organization acquiredin 2003, developse and markets portable personal health record and health management Mark L. Weinstein, Bio-Imaging’sx president and CEO, said the sale of CapMed will allow Bio-Imaginvg (NASDAQ:BITI) to focus all its effort on the company’s core businesa of providing clinical trialservicexs — including medical image management and electronic data capture servicees — that support product development by pharmaceutical, biotechnologgy and medical device companies.
“While CapMed’s businesxs of providing consumer centric interoperable personal healthg management solutions will be an integral component in theevolving health-carwe system, we believe that it is beneficial for all partiees that CapMed will be a part of an organizatioj that is more closely aligned with health-carew information and payment processing for consumers,” Weinstein